Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • Booktopia reports soft quarter after Black Friday season as Aussies opt for more cost-effective literature
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Booktopia reports soft quarter after Black Friday season as Aussies opt for more cost-effective literature
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • Booktopia reports soft quarter after Black Friday season as Aussies opt for more cost-effective literature
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • Booktopia reports soft quarter after Black Friday season as Aussies opt for more cost-effective literature
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • Booktopia reports soft quarter after Black Friday season as Aussies opt for more cost-effective literature
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Refurbished tech pivot gathers momentum as Harris Technology’s margins expand and cash flow turns positive
    Refurbished tech pivot gathers momentum as Harris Technology’s margins expand and cash flow turns positive
    • News

  • Harris Technology targets return to profitability amid surging Refurbished Tech sales and Apple expansion
    Harris Technology targets return to profitability amid surging Refurbished Tech sales and Apple expansion
    • News

  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians
    Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians
    • News

  • Harris Technology secures major investment from Taiwan’s FSP Technology at 100% premium
    Harris Technology secures major investment from Taiwan's FSP Technology at 100% premium
    • News

  • Webcentral enters agreement to partially sell its domains business at mammoth valuation
    • News

    Webcentral enters agreement to partially sell its domains business at mammoth valuation

    Digital services company Webcentral (ASX: WCG) has pulled off a substantial M&A coup having secured an agreement to sell two-thirds of its domains business for $165 million. Making the deal most remarkable is the fact Webcentral was trading with a market cap of just $36 million ($0.11 per share) prior to the deal being formalised.  

    Read More
    Public
  • Algorae Pharmaceuticals collaborates with UNSW for AI biopharmaceutical prediction platform for dementia and heart diseases
    • News

    Algorae Pharmaceuticals collaborates with UNSW for AI biopharmaceutical prediction platform for dementia and heart diseases

    As of 2023, over 400,000 Australians live with dementia, with over a million people assigned to their care. It is the second leading cause of death in the country overall and the leading cause of death in women. What’s worse, Australia’s growing ageing population makes this statistic all the more worrying.  In a bid to

    Read More
    Public
  • G8 sells off 31 underperforming childcare centres to Genius Education for reallocation of resources
    • News

    G8 sells off 31 underperforming childcare centres to Genius Education for reallocation of resources

    Early education provider G8 Education (ASX: GEM) has signed a conditional agreement to sell 31 centres to TAK Operations, part of the private national childcare provider Genius Education Group. What’s more, G8 will pay $26.5 million to Genius, comprising transaction costs and adjustments, with the funds to be allocated across its 31 centres. The 31

    Read More
    Public
  • Mad Paws inches closer towards cash flow positivity as Aussies won’t hold back on pet care spending
    • News

    Mad Paws inches closer towards cash flow positivity as Aussies won’t hold back on pet care spending

    With one of the world’s highest pet ownership rates at 69%, Australia’s 2022 national pet survey reveals Aussies spare no expense in caring for their pets, of which they are parting with over $33.2 billion per year for the well-being, including food, grooming, and accessories of their beloved fur friends.  Online pet ecosystem operator Mad

    Read More
    Public
  • Dumb Ways to Die: the viral audio that perked up PlaySide’s revenue
    • News

    Dumb Ways to Die: the viral audio that perked up PlaySide’s revenue

    You’ve probably heard the Dumb Ways to Die audio while scrolling on Instagram or TikTok, but did you know where it’s from? The Melbourne rail campaign, Dumb Ways to Die—the franchise which has been under Aussie video game developer PlaySide Studios (ASX: PLY) for about two years now. Besides that, the studio has a broad

    Read More
    Public
  • Harris Technology to expand private label tech products into Australia in time for retail season
    • News

    Harris Technology to expand private label tech products into Australia in time for retail season

    As consumers around the world face inflationary pressures, there has been a rising trend towards low-cost alternative tech products, a trend that eCommerce company Harris Technology (ASX: HT8) is capitalising on overseas and is set to make these products available to Australians in time for Christmas. Over the past 12 months, Australia’s retail industry has

    Read More
    Public
  • Reduced household budgets hurt Cluey’s revenue, cost-cutting measures introduced
    • News

    Reduced household budgets hurt Cluey’s revenue, cost-cutting measures introduced

    Even after its cost-cutting initiatives proved helpful, tutoring firm Cluey (ASX: CLU) has been dealing with setbacks in the face of reduced household budgets. The Company reported a 17% decline in revenue, with earnings taking a hit. In Q1 FY24, the EdTech company made notable improvements in its financial performance in other areas. The Company

    Read More
    Public
  • After selling US arm to focus on Australia, PointsBet gets the winning ball rolling
    • News

    After selling US arm to focus on Australia, PointsBet gets the winning ball rolling

    While most companies create grand plans to enter the US, online wagering company PointsBet (ASX: PBH) is glad to wash its hand off its American arm since selling it off to Fanatics Betting and Gaming in August 2023.  With the first installment of $275.4 million being received, PointsBet is finally focusing on its Australian and

    Read More
    Public
  • IncentiaPay rejects takeover offer, cites undervaluation and uncertainty
    • News

    IncentiaPay rejects takeover offer, cites undervaluation and uncertainty

    Loyalty pays. Just ask IncentiaPay (ASX: INP) which has firmly rejected an unsolicited takeover proposal from a Melbourne-based loyalty and rewards program operator with a focus on the dining sector. The indicative offer, made on October 20, 2023, sought to acquire 100% of the IncentiaPay’s shares for a cash value of $0.0049 per share. INP

    Read More
    Public
  • Syntara accelerates clinical trials and blood cancer drug pipeline following mannitol business sale
    • News

    Syntara accelerates clinical trials and blood cancer drug pipeline following mannitol business sale

    Syntara – it’s a name that biotech investors will be hearing a lot in the years to come with the Company set to accelerate clinical development of its novel drugs to treat blood cancers.  Syntara* will be the new name for Pharmaxis (ASX: PXS) which has sold its mannitol respiratory business and is pursuing an

    Read More
    Public
  • «
  • ‹
  • 75
  • 76
  • 77
  • 78
  • 79
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.